Hola,
Are you new here?

Time2SWITCH

financed

Bioorthogonal Iontronic Chemistry: Spatiotemporal Drug Release with Electronic P...

Bioorthogonal Iontronic Chemistry: Spatiotemporal Drug Release with Electronic Precision I envision a new drug delivery system capable spatiotemporal release with electronic precision.This technology is based on; Biontronic Chemistry (BC) which combines Bioorthogonal Release (BR) and Iontronic transport to overcome th... see more

31/08/2029

TU WIEN

1M€

Project Budget: 1M€

Project leader

TECHNISCHE UNIVERSITAET WIEN No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

PARTICIPATION DEPralty Sin fecha límite de participación.

Financing granted El organismo HORIZON EUROPE notifico la concesión del proyecto The day 2024-09-01

ERC-2023-STG: ERC STARTING GRANTS Scope:Objectives

I+D

Cerrada

0% 100%

characteristics of the participant

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Private Information

No hay información privada compartida para este proyecto. Habla con el coordinador.

Participantes

TU WIEN

Leader

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Project duration: 59 months Date Start: 2024-09-01
End date: 2029-08-31

Project leader

TECHNISCHE UNIVERSITAET WIEN No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Project Budget 1M€

participation deadline Sin fecha límite de participación.

Project description I envision a new drug delivery system capable spatiotemporal release with electronic precision.This technology is based on; Biontronic Chemistry (BC) which combines Bioorthogonal Release (BR) and Iontronic transport to overcome the drawbacks of each individual technology and combine their unique advantages. An electronic ion pump (IP) will enable programable electrophoretic transport of chemical triggers without liquid flow or moving mechanical parts to initiate the ultrafast & selective bioorthogonal release (BR) of drugs at the target site to generate previously unobtainable dynamic concentration-time profiles. Hence, BC translates electrical stimuli, of arbitrary frequencies and amplitudes, into tailor-made bio-chemical concentration/time profiles. By incorporating surface release functionalities and orthogonal bioorthogonal chemistries I will further expand the concept and demonstrate choreographed cascade releases to afford individually programmable release of multiple compounds with distinct concentration/time profiles. We will map out this large parameter space using a combination of rational chemical design, computationally aided device physics and engineering, fluorescent model systems and finally evaluation in cell models. T2S will lay the foundation for new directions in science and offer unprecedented opportunities for various therapies wherein choreographed, spatiotemporal control of multiple drug release is key (e.g. cancer; nerve regeneration and aging). My hypothesis is that if we combine local drug delivery and chronotherapy, we can dramatically increase treatment efficacy and reduce (if not completely) eliminate side effects. My overarching goal is to create a Switch that elevates medicine to the 5th dimension (5D) thus paving the way towards a paradigm shift in drug delivery and our understanding/ability to manipulate biological-spacetime by delivering the right dose (1D) at the right place (3D) at the right time (1D).

Conecta tu I+D

Entra hoy

Forgot your password?

Financing

Companies

CTIs/Universidades

Projects

researchers